Meeting the Challenges of IBD Management in the Era of COVID-19: A Panel Case Review & Discussion

We have surveyed inflammatory bowel disease (IBD) providers around the country to find what cases they have struggled with when their patients with IBD concurrently developed COVID-19. In this activity, an IBD expert panel has been convened to discuss cases submitted by these physicians and answer questions such as, do biologics need to be interrupted? Do mRNA vaccines work when a patient is on a biologic? Do the COVID-19 vaccines cause IBD to flare? The panel takes on these timely questions and introduces you to a novel clinical decision support tool that you can access right now to help you assess your patients’ IBD complication risk and predict their response to biologics. The panel directly demonstrates how to utilize this free tool to manage IBD in these challenging cases, how your colleagues have been using it already, and how you can take advantage of it too.